| Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia … RP Giugliano, NR Desai, P Kohli, WJ Rogers, R Somaratne, F Huang, ... The Lancet 380 (9858), 2007-2017, 2012 | 563 | 2012 |
| Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness BD Levy, P Kohli, K Gotlinger, O Haworth, S Hong, S Kazani, E Israel, ... The Journal of Immunology 178 (1), 496-502, 2007 | 411 | 2007 |
| Resolvins and protectins: mediating solutions to inflammation P Kohli, BD Levy British journal of pharmacology 158 (4), 960-971, 2009 | 361 | 2009 |
| Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury K Fukunaga, P Kohli, C Bonnans, LE Fredenburgh, BD Levy The Journal of Immunology 174 (8), 5033-5039, 2005 | 306 | 2005 |
| Role of ST2 in non–ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial P Kohli, MP Bonaca, R Kakkar, AY Kudinova, BM Scirica, MS Sabatine, ... Clinical chemistry 58 (1), 257-266, 2012 | 228 | 2012 |
| AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein (a) in hypercholesterolemic patients receiving statin … NR Desai, P Kohli, RP Giugliano, ML O’Donoghue, R Somaratne, J Zhou, ... Circulation 128 (9), 962-969, 2013 | 197 | 2013 |
| Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study P Kohli, L Wallentin, E Reyes, J Horrow, S Husted, DJ Angiolillo, ... Circulation 127 (6), 673-680, 2013 | 120 | 2013 |
| Cardiac biomarkers: what is and what can be R Jacob, M Khan Indian journal of cardiovascular disease in women WINCARS 3 (4), 240, 2018 | 99 | 2018 |
| NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease P Kohli, PG Steg, CP Cannon, SC Smith Jr, KA Eagle, EM Ohman, ... The American Journal of Medicine 127 (1), 53-60. e1, 2014 | 83 | 2014 |
| A clinician's guide to the ABCs of cardiovascular disease prevention: the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease and American College of Cardiology … S Hsu, VK Ton, M Dominique Ashen, SS Martin, TJ Gluckman, P Kohli, ... Clinical Cardiology 36 (7), 383-393, 2013 | 64 | 2013 |
| AMG 145, a Monoclonal Antibody Against PCSK9, Facilitates Achievement of National Cholesterol Education Program–Adult Treatment Panel III Low-Density Lipoprotein Cholesterol … NR Desai, RP Giugliano, J Zhou, P Kohli, R Somaratne, E Hoffman, T Liu, ... Journal of the American College of Cardiology 63 (5), 430-433, 2014 | 62 | 2014 |
| Design and rationale of the LAPLACE‐TIMI 57 trial: a phase II, double‐blind, placebo‐controlled study of the efficacy and tolerability of a monoclonal antibody inhibitor of … P Kohli, NR Desai, RP Giugliano, JB Kim, R Somaratne, F Huang, ... Clinical cardiology 35 (7), 385-391, 2012 | 59 | 2012 |
| Risk of New-Onset Diabetes and Cardiovascular Risk Reduction From High-Dose Statin Therapy in Pre-Diabetics and Non–Pre-Diabetics: An Analysis From TNT … P Kohli, DD Waters, R Nemr, BJ Arsenault, M Messig, DA DeMicco, ... Journal of the American College of Cardiology 65 (4), 402-404, 2015 | 56 | 2015 |
| Clinical trial participation after myocardial infarction in a national cardiovascular data registry JA Udell, TY Wang, S Li, P Kohli, MT Roe, JA de Lemos, SD Wiviott Jama 312 (8), 841-843, 2014 | 52 | 2014 |
| HIV and Hepatitis C–Coinfected Patients Have Lower Low‐Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK 9): An Apparent “PCSK 9 … P Kohli, P Ganz, Y Ma, R Scherzer, S Hur, B Weigel, C Grunfeld, S Deeks, ... Journal of the American Heart Association 5 (5), e002683, 2016 | 51 | 2016 |
| Surfing the waves of the COVID-19 pandemic as a cardiovascular clinician P Kohli, SS Virani Circulation 142 (2), 98-100, 2020 | 48 | 2020 |
| Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON–TIMI 38 study … P Kohli, JA Udell, SA Murphy, CP Cannon, EM Antman, E Braunwald, ... Journal of the American College of Cardiology 63 (3), 225-232, 2014 | 45 | 2014 |
| Clinician's Guide to the Updated ABC s of Cardiovascular Disease Prevention P Kohli, SP Whelton, S Hsu, CW Yancy, NJ Stone, J Chrispin, NA Gilotra, ... Journal of the American Heart Association 3 (5), e001098, 2014 | 42 | 2014 |
| Omega-3 fatty acid and cardiovascular outcomes: insights from recent clinical trials X Jia, P Kohli, SS Virani Current Atherosclerosis Reports 21, 1-7, 2019 | 30 | 2019 |
| Hypertriglyceridemia: a simple approach to identify insulin resistance and enhanced cardio-metabolic risk in patients with prediabetes F Abbasi, P Kohli, GM Reaven, JW Knowles diabetes research and clinical practice 120, 156-161, 2016 | 29 | 2016 |
